These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 26616828)

  • 1. [When muscle relaxants have unexpected prolonged duration during anaesthesia].
    Madsen MV; Øberg E; Rosenberg J; Gätke MR
    Ugeskr Laeger; 2015 Nov; 177(47):V04150300. PubMed ID: 26616828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monitoring of neuromuscular blockade in general anaesthesia.
    Smith A
    Lancet; 2010 Jul; 376(9735):77-9. PubMed ID: 20621223
    [No Abstract]   [Full Text] [Related]  

  • 3. Failure to reverse prolonged vecuronium-induced neuromuscular blockade with edrophonium in an anesthetized dog.
    Martin-Flores M; Boesch J; Campoy L; Gleed RD
    J Am Anim Hosp Assoc; 2011; 47(4):294-8. PubMed ID: 21673340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuromuscular blockade in the elderly.
    Stankiewicz-Rudnicki M
    Anaesthesiol Intensive Ther; 2016; 48(4):257-260. PubMed ID: 27797097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The RECITE Study: A Canadian Prospective, Multicenter Study of the Incidence and Severity of Residual Neuromuscular Blockade.
    Fortier LP; McKeen D; Turner K; de Médicis É; Warriner B; Jones PM; Chaput A; Pouliot JF; Galarneau A
    Anesth Analg; 2015 Aug; 121(2):366-72. PubMed ID: 25902322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Guidelines on muscle relaxants and reversal in anaesthesia.
    Plaud B; Baillard C; Bourgain JL; Bouroche G; Desplanque L; Devys JM; Fletcher D; Fuchs-Buder T; Lebuffe G; Meistelman C; Motamed C; Raft J; Servin F; Sirieix D; Slim K; Velly L; Verdonk F; Debaene B
    Anaesth Crit Care Pain Med; 2020 Feb; 39(1):125-142. PubMed ID: 31926308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recommendations on the use of deep neuromuscular blockade by anaesthesiologists and surgeons. AQUILES (Anestesia QUIrúrgica para Lograr Eficiencia y Seguridad) Consensus.
    Errando-Oyonarte CL; Moreno-Sanz C; Vila-Caral P; Ruiz de Adana-Belbel JC; Vázquez-Alonso E; Ramírez-Rodríguez JM; Veiga-Ruiz G; Guasch-Arévalo E; Lora-Tamayo D'Ocón JI
    Rev Esp Anestesiol Reanim; 2017 Feb; 64(2):95-104. PubMed ID: 27692692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Neuromuscular monitoring].
    Mencke T; Schmartz D; Fuchs-Buder T
    Anaesthesist; 2013 Oct; 62(10):847-61. PubMed ID: 24150775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reversal of neuromuscular blockade.
    Ramsey FM
    Int Anesthesiol Clin; 1991; 29(2):93-104. PubMed ID: 2071225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safe use of muscle relaxants in day care.
    van den Broek L
    Acta Anaesthesiol Belg; 1997; 48(1):23-7. PubMed ID: 9099305
    [No Abstract]   [Full Text] [Related]  

  • 11. Myths and facts in neuromuscular pharmacology. New developments in reversing neuromuscular blockade.
    Fink H; Hollmann MW
    Minerva Anestesiol; 2012 Apr; 78(4):473-82. PubMed ID: 22454044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Muscle relaxants suitable for day case surgery.
    Geldner G; Wulf H
    Eur J Anaesthesiol Suppl; 2001; 23():43-6. PubMed ID: 11766246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Residual neuromuscular blockade in critical care.
    Wilson J; Collins AS; Rowan BO
    Crit Care Nurse; 2012 Jun; 32(3):e1-9; quiz e10. PubMed ID: 22661165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Neuromuscular blockades. Agents, monitoring and antagonism].
    Schreiber JU; Fuchs-Buder T
    Anaesthesist; 2006 Nov; 55(11):1225-35; quiz 1236. PubMed ID: 17082884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Impact of a quality assurance program on the use of neuromuscular monitoring and reversal of muscle relaxants].
    Motamed C; Bourgain JL
    Ann Fr Anesth Reanim; 2009 Apr; 28(4):297-301. PubMed ID: 19304447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional recovery after neuromuscular blockade in mechanically ventilated critically ill patients.
    Whetstone Foster JG; Clark AP
    Heart Lung; 2006; 35(3):178-89. PubMed ID: 16701112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of neuromuscular blockade on operating conditions during general anesthesia for spinal surgery.
    Li YL; Liu YL; Xu CM; Lv XH; Wan ZH
    J Neurosurg Anesthesiol; 2014 Jan; 26(1):45-9. PubMed ID: 23887680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Use of neuromuscular blocking agents and reversal of blockade: guidelines from Sociedad Española de Anestesiología, Reanimación y Terapéutica del Dolor].
    Alvarez Gómez JA; Ariño Irujo JJ; Errando Oyonarte CL; Matínez Torrente F; Roigé i Solé J; Gilsanz Rodríguez F;
    Rev Esp Anestesiol Reanim; 2009 Dec; 56(10):616-27. PubMed ID: 20151524
    [No Abstract]   [Full Text] [Related]  

  • 19. Avoiding the pitfalls and ensuring the safety of sustained neuromuscular blockade.
    Burton S; Alexander E
    AACN Adv Crit Care; 2006; 17(3):239-43. PubMed ID: 16931917
    [No Abstract]   [Full Text] [Related]  

  • 20. Residual paralysis: a real problem or did we invent a new disease?
    Donati F
    Can J Anaesth; 2013 Jul; 60(7):714-29. PubMed ID: 23625545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.